Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes,...
COUR Pharmaceuticals, a biotechnology company developing novel immune-modifying nanoparticles (CNPs) to treat immune disorders, today announced the U.S. Food and Drug Administration (FDA) granted...
ZIVO Bioscience, Inc., a biotech/agtech R&D company engaged in the development and commercialization of therapeutic, medicinal and nutritional product candidates derived from proprietary algal...
With a steadfast commitment to protecting personal healthcare information, Coriell Life Sciences (CLS) – a leader in precision medicine dedicated to personalized medication safety...
Amgen and BioLabs LA at the Lundquist Institute announced that Karma Biotechnologies has been awarded the second Amgen Golden Ticket in Southern California. Karma...
